D.E. Shaw & Co’s OncoMed Pharmaceuticals, Inc. OMED Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q2 | – | Sell |
-84,433
| Closed | -$88K | – | 2868 |
|
2019
Q1 | $88K | Sell |
84,433
-71,816
| -46% | -$74.9K | ﹤0.01% | 2457 |
|
2018
Q4 | $117K | Sell |
156,249
-171,920
| -52% | -$129K | ﹤0.01% | 2446 |
|
2018
Q3 | $696K | Buy |
328,169
+1,900
| +0.6% | +$4.03K | ﹤0.01% | 1963 |
|
2018
Q2 | $754K | Buy |
326,269
+19,506
| +6% | +$45.1K | ﹤0.01% | 1998 |
|
2018
Q1 | $976K | Buy |
306,763
+25,833
| +9% | +$82.2K | ﹤0.01% | 1825 |
|
2017
Q4 | $1.15M | Buy |
280,930
+122,914
| +78% | +$504K | ﹤0.01% | 1774 |
|
2017
Q3 | $714K | Buy |
158,016
+102,549
| +185% | +$463K | ﹤0.01% | 1935 |
|
2017
Q2 | $185K | Buy |
55,467
+33,623
| +154% | +$112K | ﹤0.01% | 2273 |
|
2017
Q1 | $201K | Buy |
+21,844
| New | +$201K | ﹤0.01% | 2282 |
|
2015
Q4 | – | Sell |
-18,112
| Closed | -$300K | – | 2921 |
|
2015
Q3 | $300K | Buy |
18,112
+8,557
| +90% | +$142K | ﹤0.01% | 2230 |
|
2015
Q2 | $215K | Buy |
+9,555
| New | +$215K | ﹤0.01% | 2452 |
|
2013
Q4 | – | Sell |
-47,733
| Closed | -$731K | – | 2840 |
|
2013
Q3 | $731K | Buy |
+47,733
| New | +$731K | ﹤0.01% | 1721 |
|